S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
CEO of America's biggest bank has stern warning (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
CEO of America's biggest bank has stern warning (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The AI Singularity Clock Is Ticking (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
CEO of America's biggest bank has stern warning (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
CEO of America's biggest bank has stern warning (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The AI Singularity Clock Is Ticking (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
CEO of America's biggest bank has stern warning (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
CEO of America's biggest bank has stern warning (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The AI Singularity Clock Is Ticking (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
CEO of America's biggest bank has stern warning (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
CEO of America's biggest bank has stern warning (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The AI Singularity Clock Is Ticking (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
NYSE:IBER

Ibere Pharmaceuticals (IBER) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.18
$10.18
50-Day Range
$10.15
$10.21
52-Week Range
$9.74
$10.75
Volume
44,499 shs
Average Volume
110,000 shs
Market Capitalization
$175.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IBER stock logo

About Ibere Pharmaceuticals Stock (NYSE:IBER)

Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.


IBER Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive IBER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ibere Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Holding & other investment offices
Sub-Industry
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$1.56 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.09 per share
Book Value
($0.63) per share

Miscellaneous

Free Float
13,800,000
Market Cap
$175.61 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Osagie O. Imasogie Esq. (Age 61)
    Chairman & CEO
  • Ms. Lisa M. Gray CPA (Age 58)
    CPA, CVA, CFO, Exec. VP & Director
  • Mr. Zoltan Kerekes J.D. (Age 57)
    COO, Exec. VP & Director

This page (NYSE:IBER) was last updated on 2/25/2024 by MarketBeat.com Staff